. Author manuscript; available in PMC: 2013 Oct 21.

Published in final edited form as: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD005656. doi: 10.1002/14651858.CD005656.pub2

Characteristics of ongoing studies.

Ip 2004
Study name	A randomized trial comparing intravitreal triamcinolone acetonide and laser photocoagulation for DME.
Methods
Participants	Patients 18 years of age and older with diabetes mellitus and macular edema in one or both eyes may be eligible for this study.
Interventions	1) Intravitreal injection of 1 mg of triamcinolone acetonide; 2) Intravitreal injection of 4 mg of triamcinolone acetonide; 3) standard of care group: conventional treatment consisting of focal/grid photocoagulation.
Outcomes	Primary: Visual acuity (measured with Electronic-ETDRS) Secondary: Retinal thickening (measured on OCT).
Starting date	June 2004
Contact information	Michael Ip, MD University of Wisconsin Medical School Fundus Photograph Reading Center Park West One 406 Science Drive, Suite 400 Madison, WI 53711 msip@facstaff.wisc.edu Phone: 608-263-5749 Fax: 608-263-0525
Notes	Primary outcome at 3 years (preliminary outcome assessment at 1 year) Planned sample size: 795 patients.

DME: diabetic macular edema

ETDRS: Early Treatment Diabetic Retinopath Study

OCT: optical coherence tomography